saccharomyces boulardii and Reduced Nausea Incidence Doses used in studies
mg/day: 500–1,000 (median 750, IQR 500–1,000) — 1 study Safety in these studies
abdominal distention Increased risk RR = 0.39, 95% CI: 0.26-0.59
abdominal distention (RR = 0.39, 95% CI: 0.26-0.59)
from: Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicoba constipation Increased risk RR = 0.32, 95% CI: 0.18-0.55
constipation (RR = 0.32, 95% CI: 0.18-0.55)
from: Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicoba diarrhea Increased risk RR = 0.28, 95% CI: 0.22-0.36
Specifically, it reduced the incidence of some gastrointestinal adverse effects and nonspecific adverse effects, including diarrhea (RR = 0.28, 95% CI: 0.22-0.36)
from: Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicoba nausea Increased risk RR = 0.59, 95% CI: 0.36-0.97
nausea (RR = 0.59, 95% CI: 0.36-0.97)
from: Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicoba rash Increased risk RR = 0.49, 95% CI: 0.28-0.86
rash (RR = 0.49, 95% CI: 0.28-0.86)
from: Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicoba Overall tolerability Reported
S. boulardii supplementation to bismuth quadruple therapy significantly improved H. pylori eradication rates (RR = 1.08, 95% CI: 1.04-1.12) and reduced the incidence of total adverse effects (RR = 0.53, 95% CI: 0.45-0.62).
from: Effect of Saccharomyces boulardii supplementation to bismuth quadruple therapy on Helicoba 2 of 2 papers Population: All (2) Clinical (1) Unspecified (1)
2023-12-15 Meta-Analysis · n = 2,156 BMC infectious diseases 23(1) Lian-Hua Liu Bin Han Jing Tao Kai Zhang Xi-Ke Wang Wen-Yu Wang nausea (n = 11 RCTs, 12.7% vs. 21.3%, RR = 0.53, 95% CI: 0.40-0.72, P < 0.0001)
Effect Beneficial Effect size Large Significant Yes 2025-04-18 Meta-Analysis BMC gastroenterology 25(1) Yi-Zhou Jiang Kai Ma Cheng Cui Zhuo-Ya Li Xiao-Yong Wang nausea (RR = 0.59, 95% CI: 0.36-0.97)
Effect Beneficial Effect size Moderate Significant Yes Dose 500 mg/day or 1000 mg/day